To determine if the MDR1n regulatory element could further decrease the Ad-p14ARF-p14-tBID construct’s activation in human cancer cell lines with a different Ras and p53 status, we constructed the modified p14ARF-p14-tBID construct ± MDR1n. Here, TP53 is linked to cancer.